3D Optical Surface Profilers (Profilometers)
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Prostacyclin Market Outlook 2023
1 Prostacyclin Market Overview
1.1 Product Overview and Scope of Prostacyclin
1.2 Prostacyclin Segment by Type
1.2.1 Global Prostacyclin Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Epoprostenol Sodium
1.2.3 Treprostinil
1.2.4 Iloprost
1.2.5 Beraprost Sodium
1.3 Prostacyclin Segment by Application
1.3.1 Global Prostacyclin Sales Comparison by Application: (2021-2027)
1.3.2 For Injection
1.3.3 For Oral
1.3.4 For Inhalation
1.4 Global Prostacyclin Market Size Estimates and Forecasts
1.4.1 Global Prostacyclin Revenue 2016-2027
1.4.2 Global Prostacyclin Sales 2016-2027
1.4.3 Prostacyclin Market Size by Region: 2016 Versus 2021 Versus 2027
2 Prostacyclin Market Competition by Manufacturers
2.1 Global Prostacyclin Sales Market Share by Manufacturers (2016-2021)
2.2 Global Prostacyclin Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Prostacyclin Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Prostacyclin Manufacturing Sites, Area Served, Product Type
2.5 Prostacyclin Market Competitive Situation and Trends
2.5.1 Prostacyclin Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Prostacyclin Players Market Share by Revenue
2.5.3 Global Prostacyclin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prostacyclin Retrospective Market Scenario by Region
3.1 Global Prostacyclin Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Prostacyclin Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Prostacyclin Market Facts & Figures by Country
3.3.1 North America Prostacyclin Sales by Country
3.3.2 North America Prostacyclin Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Prostacyclin Market Facts & Figures by Country
3.4.1 Europe Prostacyclin Sales by Country
3.4.2 Europe Prostacyclin Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Prostacyclin Market Facts & Figures by Region
3.5.1 Asia Pacific Prostacyclin Sales by Region
3.5.2 Asia Pacific Prostacyclin Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Prostacyclin Market Facts & Figures by Country
3.6.1 Latin America Prostacyclin Sales by Country
3.6.2 Latin America Prostacyclin Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Prostacyclin Market Facts & Figures by Country
3.7.1 Middle East and Africa Prostacyclin Sales by Country
3.7.2 Middle East and Africa Prostacyclin Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Prostacyclin Historic Market Analysis by Type
4.1 Global Prostacyclin Sales Market Share by Type (2016-2021)
4.2 Global Prostacyclin Revenue Market Share by Type (2016-2021)
4.3 Global Prostacyclin Price by Type (2016-2021)
5 Global Prostacyclin Historic Market Analysis by Application
5.1 Global Prostacyclin Sales Market Share by Application (2016-2021)
5.2 Global Prostacyclin Revenue Market Share by Application (2016-2021)
5.3 Global Prostacyclin Price by Application (2016-2021)
6 Key Companies Profiled
6.1 United Therapeutics
6.1.1 United Therapeutics Corporation Information
6.1.2 United Therapeutics Description and Business Overview
6.1.3 United Therapeutics Prostacyclin Sales, Revenue and Gross Margin (2016-2021)
6.1.4 United Therapeutics Prostacyclin Product Portfolio
6.1.5 United Therapeutics Recent Developments/Updates
6.2 Actelion (J & J)
6.2.1 Actelion (J & J) Corporation Information
6.2.2 Actelion (J & J) Description and Business Overview
6.2.3 Actelion (J & J) Prostacyclin Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Actelion (J & J) Prostacyclin Product Portfolio
6.2.5 Actelion (J & J) Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Prostacyclin Sales, Revenue and Gross Margin (2016-2021)
6.3.4 GSK Prostacyclin Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Prostacyclin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Teva Prostacyclin Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Toray
6.5.1 Toray Corporation Information
6.5.2 Toray Description and Business Overview
6.5.3 Toray Prostacyclin Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Toray Prostacyclin Product Portfolio
6.5.5 Toray Recent Developments/Updates
6.6 Tide Pharma
6.6.1 Tide Pharma Corporation Information
6.6.2 Tide Pharma Description and Business Overview
6.6.3 Tide Pharma Prostacyclin Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Tide Pharma Prostacyclin Product Portfolio
6.6.5 Tide Pharma Recent Developments/Updates
6.7 Bayer AG
6.6.1 Bayer AG Corporation Information
6.6.2 Bayer AG Description and Business Overview
6.6.3 Bayer AG Prostacyclin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bayer AG Prostacyclin Product Portfolio
6.7.5 Bayer AG Recent Developments/Updates
7 Prostacyclin Manufacturing Cost Analysis
7.1 Prostacyclin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Prostacyclin
7.4 Prostacyclin Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Prostacyclin Distributors List
8.3 Prostacyclin Customers
9 Prostacyclin Market Dynamics
9.1 Prostacyclin Industry Trends
9.2 Prostacyclin Growth Drivers
9.3 Prostacyclin Market Challenges
9.4 Prostacyclin Market Restraints
10 Global Market Forecast
10.1 Prostacyclin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Prostacyclin by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Prostacyclin by Type (2022-2027)
10.2 Prostacyclin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Prostacyclin by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Prostacyclin by Application (2022-2027)
10.3 Prostacyclin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Prostacyclin by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Prostacyclin by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Prostacyclin Sales (K Unit) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Prostacyclin Sales (K Unit) Comparison by Application (2021-2027)
Table 3. Global Prostacyclin Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Prostacyclin Covered in This Study
Table 5. Global Prostacyclin Sales (K Unit) of Key Manufacturers (2016-2021)
Table 6. Global Prostacyclin Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Prostacyclin Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Prostacyclin Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Prostacyclin Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Prostacyclin Manufacturing Sites and Area Served
Table 11. Manufacturers Prostacyclin Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Prostacyclin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostacyclin as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Prostacyclin Sales by Region (2016-2021) & (K Unit)
Table 16. Global Prostacyclin Sales Market Share by Region (2016-2021)
Table 17. Global Prostacyclin Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Prostacyclin Sales by Country (2016-2021) & (K Unit)
Table 19. North America Prostacyclin Sales Market Share by Country (2016-2021)
Table 20. North America Prostacyclin Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Prostacyclin Revenue Market Share by Country (2016-2021)
Table 22. Europe Prostacyclin Sales by Country (2016-2021) & (K Unit)
Table 23. Europe Prostacyclin Sales Market Share by Country (2016-2021)
Table 24. Europe Prostacyclin Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Prostacyclin Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Prostacyclin Sales by Region (2016-2021) & (K Unit)
Table 27. Asia Pacific Prostacyclin Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Prostacyclin Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Prostacyclin Revenue Market Share by Region (2016-2021)
Table 30. Latin America Prostacyclin Sales by Country (2016-2021) & (K Unit)
Table 31. Latin America Prostacyclin Sales Market Share by Country (2016-2021)
Table 32. Latin America Prostacyclin Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Prostacyclin Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Prostacyclin Sales by Country (2016-2021) & (K Unit)
Table 35. Middle East and Africa Prostacyclin Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Prostacyclin Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Prostacyclin Revenue Market Share by Country (2016-2021)
Table 38. Global Prostacyclin Sales (K Unit) by Type (2016-2021)
Table 39. Global Prostacyclin Sales Market Share by Type (2016-2021)
Table 40. Global Prostacyclin Revenue (Million US$) by Type (2016-2021)
Table 41. Global Prostacyclin Revenue Share by Type (2016-2021)
Table 42. Global Prostacyclin Price (USD/Unit) by Type (2016-2021)
Table 43. Global Prostacyclin Sales (K Unit) by Application (2016-2021)
Table 44. Global Prostacyclin Sales Market Share by Application (2016-2021)
Table 45. Global Prostacyclin Revenue (Million US$) by Application (2016-2021)
Table 46. Global Prostacyclin Revenue Share by Application (2016-2021)
Table 47. Global Prostacyclin Price (USD/Unit) by Application (2016-2021)
Table 48. United Therapeutics Corporation Information
Table 49. United Therapeutics Description and Business Overview
Table 50. United Therapeutics Prostacyclin Sales (K Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. United Therapeutics Prostacyclin Product
Table 52. United Therapeutics Recent Developments/Updates
Table 53. Actelion (J & J) Corporation Information
Table 54. Actelion (J & J) Description and Business Overview
Table 55. Actelion (J & J) Prostacyclin Sales (K Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Actelion (J & J) Prostacyclin Product
Table 57. Actelion (J & J) Recent Developments/Updates
Table 58. GSK Corporation Information
Table 59. GSK Description and Business Overview
Table 60. GSK Prostacyclin Sales (K Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. GSK Prostacyclin Product
Table 62. GSK Recent Developments/Updates
Table 63. Teva Corporation Information
Table 64. Teva Description and Business Overview
Table 65. Teva Prostacyclin Sales (K Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Teva Prostacyclin Product
Table 67. Teva Recent Developments/Updates
Table 68. Toray Corporation Information
Table 69. Toray Description and Business Overview
Table 70. Toray Prostacyclin Sales (K Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Toray Prostacyclin Product
Table 72. Toray Recent Developments/Updates
Table 73. Tide Pharma Corporation Information
Table 74. Tide Pharma Description and Business Overview
Table 75. Tide Pharma Prostacyclin Sales (K Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Tide Pharma Prostacyclin Product
Table 77. Tide Pharma Recent Developments/Updates
Table 78. Bayer AG Corporation Information
Table 79. Bayer AG Description and Business Overview
Table 80. Bayer AG Prostacyclin Sales (K Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Bayer AG Prostacyclin Product
Table 82. Bayer AG Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Prostacyclin Distributors List
Table 86. Prostacyclin Customers List
Table 87. Prostacyclin Market Trends
Table 88. Prostacyclin Growth Drivers
Table 89. Prostacyclin Market Challenges
Table 90. Prostacyclin Market Restraints
Table 91. Global Prostacyclin Sales Forecast by Type (2022-2027) & (K Unit)
Table 92. Global Prostacyclin Sales Market Share Forecast by Type (2022-2027)
Table 93. Global Prostacyclin Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 94. Global Prostacyclin Revenue Market Share Forecast by Type (2022-2027)
Table 95. Global Prostacyclin Sales Forecast by Application (2022-2027) & (K Unit)
Table 96. Global Prostacyclin Sales Market Share Forecast by Application (2022-2027)
Table 97. Global Prostacyclin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 98. Global Prostacyclin Revenue Market Share Forecast by Application (2022-2027)
Table 99. Global Prostacyclin Sales Forecast by Region (2022-2027) & (K Unit)
Table 100. Global Prostacyclin Sales Market Share Forecast by Region (2022-2027)
Table 101. Global Prostacyclin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 102. Global Prostacyclin Revenue Market Share Forecast by Region (2022-2027)
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Prostacyclin
Figure 2. Global Prostacyclin Market Share by Type in 2020 & 2027
Figure 3. Epoprostenol Sodium Product Picture
Figure 4. Treprostinil Product Picture
Figure 5. Iloprost Product Picture
Figure 6. Beraprost Sodium Product Picture
Figure 7. Global Prostacyclin Market Share by Application in 2020 & 2027
Figure 8. For Injection
Figure 9. For Oral
Figure 10. For Inhalation
Figure 11. Global Prostacyclin Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Prostacyclin Market Size 2016-2027 (US$ Million)
Figure 13. Global Prostacyclin Sales 2016-2027 (K Unit)
Figure 14. Global Prostacyclin Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Prostacyclin Sales Share by Manufacturers in 2020
Figure 16. Global Prostacyclin Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Prostacyclin Players: Market Share by Revenue in 2020
Figure 18. Prostacyclin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Prostacyclin Sales Market Share by Region (2016-2021)
Figure 20. Global Prostacyclin Sales Market Share by Region in 2020
Figure 21. Global Prostacyclin Revenue Market Share by Region (2016-2021)
Figure 22. Global Prostacyclin Revenue Market Share by Region in 2020
Figure 23. U.S. Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Prostacyclin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Prostacyclin by Type (2016-2021)
Figure 48. Sales Market Share of Prostacyclin by Application (2016-2021)
Figure 49. Sales Market Share of Prostacyclin by Application in 2020
Figure 50. Revenue Share of Prostacyclin by Application (2016-2021)
Figure 51. Revenue Share of Prostacyclin by Application in 2020
Figure 52. Manufacturing Cost Structure of Prostacyclin
Figure 53. Manufacturing Process Analysis of Prostacyclin
Figure 54. Prostacyclin Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
United Therapeutics Actelion (J & J) GSK Teva Toray Tide Pharma Bayer AG